Users often notice more stable blood sugar levels, reduced cravings for sugary foods, and better energy stability throughout the day
Whats actually in there? Knoepfler said
The evidence base for tirzepatide as monotherapy is robust, with pivotal trials including SURMOUNT-1 demonstrating significant weight reduction in adults with obesity, and SURPASS trials establishing glycemic efficacy in type 2 diabetes
TB-500s research base is broader but distributed across the full Thymosin Beta-4 protein literature, with fewer studies using the specific TB-500 synthetic fragment
Arcane Peptides is a chemical supplier and is not a compounding pharmacy or chemical compounding facility as defined under Section 503A of the Federal Food, Drug, and Cosmetic Act
Both compounds independently reduce local inflammatory markers in their respective model systems